About Ceres (NASDAQ:CERE)
Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds and traits to produce crops for feed, forages, sugar and other markets. The Company uses a combination of plant breeding, biotechnology and bioinformatics to develop seed products and biotechnology traits. Its Forage sorghum seeds are used for growing feed for livestock, including dairy and beef cattle. Its technology platforms have application across various end markets, including food, feed, fiber and fuel. It has developed bioinformatics software, Persephone, to deal with the data generated in plant genomics. Its Persephone enables storage and access to datasets, as well as data visualizations to view genetic data from public sources and databases. It markets its seed products under the name Blade. Its customers include dairies and livestock producers, agri-industrial facilities, individual growers and grower cooperatives. It deploys a range of research and development methods and tools.
Industry, Sector and Symbol:
- Industry: Renewable Fuels
- Sub-Industry: Coal & Consumable Fuels
- Sector: N/A
- Symbol: NASDAQ:CERE
- CUSIP: 15677310
- Web: ceres.net
- Trailing EPS: ($1.80)
- Net Margins: -106.36%
- Return on Equity: -319.82%
- Return on Assets: -78.47%
- Outstanding Shares: 24,510,000
Frequently Asked Questions for Ceres (NASDAQ:CERE)
What is Ceres' stock symbol?
Ceres trades on the NASDAQ under the ticker symbol "CERE."
How were Ceres' earnings last quarter?
Ceres Inc (NASDAQ:CERE) issued its earnings results on Thursday, April, 14th. The biotechnology company reported ($0.09) earnings per share for the quarter. The biotechnology company earned $0.35 million during the quarter, compared to analyst estimates of $7.60 million. Ceres had a negative return on equity of 319.82% and a negative net margin of 106.36%. View Ceres' Earnings History.
Who are some of Ceres' key competitors?
Some companies that are related to Ceres include Fibrocell Science (FCSC), Kitov Pharmaceuticals Holdings (KTOV), Netlist (NLST), Aviragen Therapeutics (AVIR), Ideal Power (IPWR), Eleven Biotherapeutics (EBIO), Euroseas (ESEA), Sonoma Pharmaceuticals (SNOA), Kona Grill (KONA), Genius Brands International (GNUS), Valeritas Holdings (VLRX), DelMar Pharmaceuticals (DMPI), Soligenix (SNGX), Cinedigm Corp (CIDM), SemiLEDS Corporation (LEDS), Biocept (BIOC), Xenetic Biosciences (XBIO) and Sphere 3D Corp. (ANY).
How do I buy Ceres stock?
Shares of Ceres can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Ceres' stock price today?
One share of Ceres stock can currently be purchased for approximately $0.40.
How big of a company is Ceres?
Ceres has a market capitalization of $11.07 million.
How can I contact Ceres?
Ceres' mailing address is 1535 Rancho Conejo Blvd, THOUSAND OAKS, CA 91320-1440, United States. The biotechnology company can be reached via phone at +1-805-3766500.
MarketBeat Community Rating for Ceres (NASDAQ CERE)MarketBeat's community ratings are surveys of what our community members think about Ceres and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Ceres (NASDAQ:CERE) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Ceres (NASDAQ:CERE)
Analysts' Ratings History for Ceres (NASDAQ:CERE)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History and Estimates Chart for Ceres (NASDAQ:CERE)
Earnings History by Quarter for Ceres (NASDAQ CERE)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/14/2016||Q216||($0.09)||$7.60 million||$0.35 million||View||N/A|
|11/23/2015||Q4||($1.26)||$2.40 million||$2.70 million||View||Listen|
|4/10/2014||Q2 14||($0.30)||($0.29)||$0.60 million||$0.50 million||View||N/A|
|1/9/2014||Q1||($0.27)||($0.33)||$0.50 million||$0.76 million||View||Listen|
|7/11/2013||Q3 2013||($0.31)||($0.38)||$1.05 million||$1.40 million||View||N/A|
|1/10/2013||Q1 2013||($0.32)||($0.28)||$1.33 million||$2.00 million||View||N/A|
Earnings Estimates for Ceres (NASDAQ:CERE)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Ceres (NASDAQ:CERE)
No dividend announcements for this company have been tracked by MarketBeat.com
Latest Headlines for Ceres (NASDAQ CERE)
Ceres (NASDAQ CERE) Chart for Wednesday, November, 22, 2017